Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol - PubMed (original) (raw)

Comparative Study

doi: 10.1002/neu.20043.

Affiliations

• PMID: 15389604
• DOI: 10.1002/neu.20043

Comparative Study

Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol

Iratxe Ciriza et al. J Neurobiol. 2004 Nov.

Abstract

Neuroprotective effects of estradiol are well characterized in animal experimental models. However, in humans, the outcome of estrogen treatment for cognitive function and neurological diseases is very controversial. Selective estrogen receptor modulators (SERMs) may represent an alternative to estrogen for the treatment or the prevention of neurodegenerative disorders. SERMs interact with the estrogen receptors and have tissue-specific effects distinct from those of estradiol, acting as estrogen agonists in some tissues and as antagonists in others. In this study we have assessed the effect of tamoxifen, raloxifene, lasofoxifene (CP-336,156), bazedoxifene (TSE-424), and 17beta-estradiol on the hippocampus of adult ovariectomized rats, after the administration of the excitotoxin kainic acid. Administration of kainic acid induced the expression of vimentin in reactive astroglia and a significant neuronal loss in the hilus. SERMs did not affect vimentin immunoreactivity in the hilus, while 17beta-estradiol significantly reduced the surface density of vimentin immunoreactive profiles. Estradiol, tamoxifen (0.4-2 mg/kg), raloxifene (0.4-2 mg/kg), and bazedoxifene (2 mg/kg) prevented neuronal loss in the hilus after the administration of kainic acid. Lasofoxifene (0.4-2 mg/kg) was not neuroprotective. These findings indicate that SERMs present different dose-dependent neuroprotective effects. Furthermore, the mechanisms of neuroprotection by SERMs and estradiol are not identical, because SERMs do not significantly affect reactive gliosis while neuroprotection by estradiol is associated with a strong down-regulation of reactive astroglia.

PubMed Disclaimer

Similar articles

• Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
  Crabtree JS, Peano BJ, Zhang X, Komm BS, Winneker RC, Harris HA. Crabtree JS, et al. Mol Cell Endocrinol. 2008 Jun 11;287(1-2):40-6. doi: 10.1016/j.mce.2008.01.027. Epub 2008 Feb 12. Mol Cell Endocrinol. 2008. PMID: 18367319
• Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
  Wang XN, Simmons HA, Salatto CT, Cosgrove PG, Thompson DD. Wang XN, et al. Menopause. 2006 Jul-Aug;13(4):609-20. doi: 10.1097/01.gme.0000227337.73738.c9. Menopause. 2006. PMID: 16837883
• The levels of glutathione and nitrite-nitrate and the expression of Bcl-2 mRNA in ovariectomized rats treated by raloxifene against kainic acid.
  Armagan G, Kanit L, Terek CM, Sozmen EY, Yalcin A. Armagan G, et al. Int J Neurosci. 2009;119(2):227-39. doi: 10.1080/00207450802330959. Int J Neurosci. 2009. PMID: 19125376
• [Next generation selective estrogen receptor modulators].
  Chaki O. Chaki O. Clin Calcium. 2006 Jan;16(1):145-52. Clin Calcium. 2006. PMID: 16397365 Review. Japanese.
• [Lasofoxifene, a next generation estrogen receptor modulator: preclinical studies].
  Maeda T, Ke HZ, Simmons H, Thompson D. Maeda T, et al. Clin Calcium. 2004 Oct;14(10):85-93. Clin Calcium. 2004. PMID: 15577137 Review. Japanese.

Cited by

• Targeting Estrogen Signaling in the Radiation-induced Neurodegeneration: A Possible Role of Phytoestrogens.
  Mitra S, Dash R, Sohel M, Chowdhury A, Munni YA, Ali MC, Hannan MA, Islam MT, Moon IS. Mitra S, et al. Curr Neuropharmacol. 2023;21(2):353-379. doi: 10.2174/1570159X20666220310115004. Curr Neuropharmacol. 2023. PMID: 35272592 Free PMC article. Review.
• Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start.
  Veenman L. Veenman L. Int J Mol Sci. 2020 Oct 14;21(20):7586. doi: 10.3390/ijms21207586. Int J Mol Sci. 2020. PMID: 33066585 Free PMC article. Review.
• Neuropsychiatric effects of tamoxifen: Challenges and opportunities.
  Novick AM, Scott AT, Neill Epperson C, Schneck CD. Novick AM, et al. Front Neuroendocrinol. 2020 Oct;59:100869. doi: 10.1016/j.yfrne.2020.100869. Epub 2020 Aug 18. Front Neuroendocrinol. 2020. PMID: 32822707 Free PMC article. Review.
• Estrogen and Serotonin: Complexity of Interactions and Implications for Epileptic Seizures and Epileptogenesis.
  Pottoo FH, Javed MN, Barkat MA, Alam MS, Nowshehri JA, Alshayban DM, Ansari MA. Pottoo FH, et al. Curr Neuropharmacol. 2019;17(3):214-231. doi: 10.2174/1570159X16666180628164432. Curr Neuropharmacol. 2019. PMID: 29956631 Free PMC article. Review.
• The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy.
  Pottoo FH, Tabassum N, Javed MN, Nigar S, Rasheed R, Khan A, Barkat MA, Alam MS, Maqbool A, Ansari MA, Barreto GE, Ashraf GM. Pottoo FH, et al. Mol Neurobiol. 2019 Feb;56(2):1233-1247. doi: 10.1007/s12035-018-1121-x. Epub 2018 Jun 7. Mol Neurobiol. 2019. PMID: 29881945

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal